Sunday, February 25, 2024 11:12:36 AM
https://schrts.co/bjmcsWKk
This is weekly 5 yr chart. Last couple years historically oscillating between $15 and $25 with no commercial ops ..... and no final anything tests in hand. IMO should already be at those levels but that's just my opinion.
ZivoLife ... producing. Albeit laughable at this point. Pending more updates on increasing commercial production. "Gut health" ..... today's big buzz words. But we know ZivoLife isn't BS and actually delivers. Over a decade of validations. Inflammation ..... inflammation ..... inflammation. ZIVO has natural answer in numerous verticals.
Coccidiosis completes final phase validation tests. Has USDA oversight and approval process determined. Has global animal health company involvement.
Tic toc tic toc ...... IMO ... if ZIVO doesnt move the product candidates to an AI style research process that can get it all done a zillion times faster ..... i'm still of the opinion ZIVO should be sold to highest bidder given it is final stage for first product candidate. There is no vision and timeline into the other possible verticals given the focus presently. Definitely ZIVO has dairy cow and porcine options in animals .... not to mention human GRAS and need to get production up to land nutraceutical ingredient business. The dried ingredient should be a hot commodity but they can't produce it in quantities.
So split it. Sell it ... split it into the biomass / ingredient .... and sell the IP and animal molecules to big pharma unless going to make major changes to the go forward process.
Amigo Mike
Recent ZIVO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:10:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:26:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 08:45:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:42:37 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 12/01/2023 10:03:58 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM